1. Stocks
    2. /
  2. Pfizer Inc. (NYSE: PFE)
    3. /

Pfizer Inc. (NYSE: PFE) Share Price and News

$24.80 $-1.22 (-4.7%) Saturday, 16 November 2024 at 8:00:00 am Australian Eastern Daylight Time

Pfizer Inc. Chart and Price Data

About Pfizer

Last updated 16-11-2024, 08:00:00am AEDT
Current Price $24.80
Change $-1.22 (-4.7%)
Close Price $24.80
Open Price $25.70
Bid $24.92
Ask $24.95
Day Range $24.48 - $25.70
Year Range $24.48 - $31.54
Volume 131,074,383
Average Volume 35,165,136
Market Cap $140,541,352,000.00
Earnings Per Share $0.74

    • Pfizer Inc. (NYSE: PFE)
    Latest News

    Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.
    International Stock News

    Why BioNTech trounced the Market on Tuesday

    | Eric Volkman

    Shareholders might be getting a small present from the company before long.

    Read more »

    The letters ETF on wooden cubes with golden coins on top of the cubes and on the ground
    ETFs

    3 ASX ETFs that could give investors easy exposure to the US markets

    | Sebastian Bowen

    Some easy ETFs for US exposure...

    Read more »

    A medical researcher in a white coat holds laboratory equipment and smiles.
    International Stock News

    Moderna's teen COVID-19 vaccine trial hits high marks

    | Cory Renauer

    The company should submit its request for the FDA to authorize the use of its vaccine in those 12 and…

    Read more »

    Medical asx share price fall represented by worried looking patient awaiting vaccine injection
    International Stock News

    Australia eyes Moderna (NASDAQ:MRNA) COVID-19 vaccine delivery

    | Aaron Teboneras

    The Moderna Inc (NASDAQ: MRNA) share price slipped overnight, despite the company announcing a deal with the Australian government.

    Read more »

    a doctor looking up at question marks
    Healthcare Shares

    What the Federal Budget could mean for CSL (ASX:CSL) shares

    | Brooke Cooper

    How shares in Australia's only vaccine manufacturer CSL Limited (ASX: CSL) might be affected by 2 key Federal Budget initiatives.

    Read more »

    health prffesional giving someone a vaccine
    International Stock News

    Pfizer and BioNTech's COVID-19 vaccine authorized by the FDA for adolescents

    | Brian Orelli, PhD

    Parents are pleased, but the move won't change much for the drug companies from a financial perspective.

    Read more »

    woman carrying out an experiment with a pipette and petri dish
    International Stock News

    If Pfizer's vaccine is a winner, why did this analyst downgrade its stock?

    | Eric Volkman

    Mizuho Securities' Vamil Divan expresses concern about the company's post-coronavirus future.

    Read more »

    Female patient receives Pfizer covid vaccine administered by female doctor
    International Stock News

    Moderna just made the Pfizer vaccine's biggest weakness an even bigger one

    | Adria Cimino

    Both vaccines do an impressive job of providing protection against COVID-19. But Moderna's is much easier to get from production…

    Read more »

    People marching and holding up anti covid vaccine signs
    Healthcare Shares

    Only 40% of Australians want the AstraZeneca vaccine. What could this mean for CSL (ASX:CSL)?

    | Marc Sidarous

    Only 40% of Australians are willing to have the AstraZeneca vaccine. What, if anything, could this mean for CSL Limited…

    Read more »

    asx share price rebound represented by wooden blocks spelling rebound with coins on top
    Healthcare Shares

    Why the CSL (ASX:CSL) share price has rebounded 13% since March

    | Aaron Teboneras

    The CSL Limited (ASX: CSL) share price is rebounding following recent developments. We take a closer look in what could…

    Read more »

    woman waering face mask holding vial of covid-19 vaccine
    Share Market News

    Wesfarmers' (ASX:WES) Bunnings open to hosting COVID vaccine hubs

    | Marc Sidarous

    Wesfarmers Ltd (ASX: WES) subsidiary, Bunnings, is open to the government using its car parks for COVID-19 mass vaccination hubs.…

    Read more »

    asx share associated with COVID vaccine represented by lab tech drawing down syringe
    International Stock News

    Pfizer to develop mRNA vaccines without BioNTech

    | Cory Renauer

    The pharmaceutical heavyweight thinks it won't need any more help to whip up new mRNA-based vaccines.

    Read more »

    Profile

    since

    Note